Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo

Nanoparticle drug delivery systems using polymers hold promise for clinical applications. We synthesized dual-ligand modified chitosan (GCGA) nanoparticles using lactic acid, glycyrrhetinic acid, and chitosan to target the liver in our previous studies. We then synthesized the GCGA/5-FU nanoparticle...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Mingrong, Gao, Xiaoyan, Wang, Yong, Chen, Houxiang, He, Bing, Li, Yingchun, Han, Jiang, Zhang, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826867/
https://www.ncbi.nlm.nih.gov/pubmed/24232303
http://dx.doi.org/10.2147/IJN.S52877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826867/
https://www.ncbi.nlm.nih.gov/pubmed/24232303
http://dx.doi.org/10.2147/IJN.S52877

Ejemplares similares